תבנית:תרופה/לוטן 100 - Lotan 100: הבדלים בין גרסאות

Hypertension: Lotan 100 is indicated for the treatment of hypertension. Heart failure:Lotan 100 is indicated for the treatment of heart failure, when treatment with an ACE inhibitor is not appropriate. Switching patients with heart failure who are stable on an ACE inhibitor to Lotan 100 is not recommended. Renal protection in Type-2 diabetic patients with proteinuria: Lotan 100 is indicated to delay the progression of renal disease as measured by a reduction in the combined incidence of doubling of serum creatinine, end stage renal disease (need for dialysis or renal transplantation) or death; and to reduce proteinuria. Reduction in the risk of cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy. Lotan 100 is indicated to reduce the risk of cardiovascular morbidity and mortality as measured by the combined incidence of cardiovascular death, stroke, and myocardial infarction in hypertensive patients with left ventricular hypertrophy. The benefit of Lotan 100 on the primary deposite endpoint was largely driven by reduction in the risk of stroke.